Greenwell M, Rahman P K S M
Int J Pharm Sci Res. 2015 Oct 1;6(10):4103-4112. doi: 10.13040/IJPSR.0975-8232.6(10).4103-12.
Globally cancer is a disease which severely effects the human population. There is a constant demand for new therapies to treat and prevent this life-threatening disease. Scientific and research interest is drawing its attention towards naturally-derived compounds as they are considered to have less toxic side effects compared to current treatments such as chemotherapy. The Plant Kingdom produces naturally occurring secondary metabolites which are being investigated for their anticancer activities leading to the development of new clinical drugs. With the success of these compounds that have been developed into staple drugs for cancer treatment new technologies are emerging to develop the area further. New technologies include nanoparticles for nano-medicines which aim to enhance anticancer activities of plant-derived drugs by controlling the release of the compound and investigating new methods for administration. This review discusses the demand for naturally-derived compounds from medicinal plants and their properties which make them targets for potential anticancer treatments.
Int J Pharm Sci Res. 2015-10-1
Ont Health Technol Assess Ser. 2006
Curr Drug Discov Technol. 2022
Endocr Metab Immune Disord Drug Targets. 2021
J Ethnopharmacol. 2021-3-25
J Ethnopharmacol. 2015-4-22
Naunyn Schmiedebergs Arch Pharmacol. 2025-9-4
Naunyn Schmiedebergs Arch Pharmacol. 2025-7-15
J Colloid Interface Sci. 2015-1-9
Phytochemistry. 2015-3
ScientificWorldJournal. 2014
Arch Biochem Biophys. 2014-6-16
Spectrochim Acta A Mol Biomol Spectrosc. 2014-3-28
Biotechnol Adv. 2014-4-1